Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chinook Therapeutics (DE:290A)
FRANKFURT:290A
RESEARCH TOOLSreports
Chinook Therapeutics (290A) Financial Statements
1 Followers
Chinook Therapeutics Financial Overview
| Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 1.83M | $ 512.00K | $ 2.50M | $ 418.00K | $ 2.70M |
| Gross Profit | $ 1.83M | $ 512.00K | - | - | - |
| EBIT | $ -61.42M | $ -62.27M | $ -49.94M | $ -38.67M | $ -31.85M |
| EBITDA | $ -61.02M | $ -61.77M | $ -48.67M | $ -37.40M | $ -30.56M |
| Net Income Common Stockholders | $ -60.14M | $ -62.62M | $ -55.98M | $ -37.65M | $ -31.68M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 350.38M | $ 378.32M | $ 373.28M | $ 362.61M | $ 276.10M |
| Total Assets | $ 543.88M | $ 574.08M | $ 590.34M | $ 601.24M | $ 531.27M |
| Total Debt | $ 38.26M | $ 39.44M | $ 40.57M | $ 41.87M | $ 43.04M |
| Net Debt | $ -312.11M | $ -338.88M | $ -332.71M | $ -320.75M | $ -233.06M |
| Total Liabilities | $ 131.48M | $ 132.14M | $ 115.70M | $ 94.11M | $ 104.47M |
| Stockholders Equity | $ 412.39M | $ 441.94M | $ 474.64M | $ 507.13M | $ 426.80M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -51.63M | $ -37.51M | $ -25.68M | $ -30.84M | $ -25.10M |
| Operating Cash Flow | $ -50.70M | $ -36.83M | $ -25.31M | $ -30.62M | $ -24.72M |
| Investing Cash Flow | $ 32.43M | $ 2.47M | $ -13.13M | $ -33.76M | $ -55.57M |
| Financing Cash Flow | $ 21.27M | $ 23.69M | $ 18.83M | $ 107.14M | $ 1.76M |
Chinook Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.